Belgrade Virus: A New Hantavirus Causing Severe Hemorrhagic Fever with Renal Syndrome in Yugoslavia

Two biologically and genetically distinct hantaviruses were isolated from blood and urine specimens collected from four Yugoslavian patients with clinically severe hemorrhagic fever with renal syndrome (HFRS). Viral isolates from three patients, designated strains Belgrade 1–3, were distinct from Ha...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases Vol. 166; no. 1; pp. 113 - 120
Main Authors: Gligic, Ana, Dimkovic, Nada, Xiao, Shu-Yuan, Buckle, Guy J., Jovanovic, Dragan, Velimirovic, Dragisa, Stojanovic, Radivoj, Obradovic, Mirceta, Diglisic, Gordana, Micic, Jasmina, Asher, David M., LeDuc, James W., Yanagihara, Richard, Carleton Gajdusek, D.
Format: Journal Article
Language:English
Published: Chicago, IL The University of Chicago Press 01-07-1992
University of Chicago Press
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Two biologically and genetically distinct hantaviruses were isolated from blood and urine specimens collected from four Yugoslavian patients with clinically severe hemorrhagic fever with renal syndrome (HFRS). Viral isolates from three patients, designated strains Belgrade 1–3, were distinct from Hantaan, Seoul, Puumala, and Prospect Hill viruses as determined by plaque-reduction neutralization tests and restriction analysis of enzymatically amplified M-segment fragments. The fourth isolate, called Kraljevo, was indistinguishable from Hantaan virus. Strains Belgrade 1 and 2, like the Kraljevo strain, caused a fatal meningoencephalitis in newborn mice inoculated with 100 pfu of virus intracerebrally and intraperitoneally. Strain Belgrade 3 was much less neurovirulent, requiring 30,000 pfu of virus to cause fatal disease in mice. These data indicate that two distinct hantaviruses, one of which constitutes a new serotype, cause clinically severe HFRS in Yugoslavia.
Bibliography:Reprints or correspondence: Dr. R. Yanagihara, National Institutes of Health. Bldg. 36. Rm. 5B-21. Bethesda. MD 20892.
istex:69551BA09AA449BE8B42E8570743E4B203EE3D35
ark:/67375/HXZ-97WXG7GQ-6
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Case Study-3
ObjectType-Article-1
ObjectType-Feature-4
ObjectType-Report-2
ISSN:0022-1899
1537-6613
DOI:10.1093/infdis/166.1.113